ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SGLB Sigma Labs Inc

1.05
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Sigma Labs Inc NASDAQ:SGLB NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.05 1.03 1.07 0 01:00:00

Statement of Changes in Beneficial Ownership (4)

26/02/2020 11:06pm

Edgar (US Regulatory)


FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

RUPORT MARK
2. Issuer Name and Ticker or Trading Symbol

SIGMA LABS, INC. [ SGLB ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Executive Chairman
(Last)          (First)          (Middle)

3900 PASEO DEL SOL
3. Date of Earliest Transaction (MM/DD/YYYY)

1/28/2020
(Street)

SANTA FE, NM 87507
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Series E Preferred Stock (1)$1.03 1/28/2020  A   33.33    1/28/2020  (1)Common Stock 63494 (2)$1500.00 33.33 D  
Warrants to Purchase Common Stock $1.13 1/28/2020  A   48544    7/29/2020 7/28/2025 Common Stock 48544 $0.00 (1)48544 D  

Explanation of Responses:
(1) Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 33.33 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 48,544 shares of the Company's Common Stock for an aggregate purchase price of $50,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date.
(2) Represents the maximum amount of common shares issuable upon conversion as described in footnote 1.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
RUPORT MARK
3900 PASEO DEL SOL
SANTA FE, NM 87507
X
Executive Chairman

Signatures
/s/ Mark K. Ruport2/26/2020
**Signature of Reporting PersonDate

1 Year Sigma Labs Chart

1 Year Sigma Labs Chart

1 Month Sigma Labs Chart

1 Month Sigma Labs Chart

Your Recent History

Delayed Upgrade Clock